Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

£0.5 Million DHT Boost for Humane Research

Published: Monday, October 29, 2012
Last Updated: Monday, October 29, 2012
Bookmark and Share
Call for applications for next wave of grant funding also announced.

The Dr Hadwen Trust (DHT) has announced grants totalling £577,687, funding innovative and humane research into Alzheimer’s disease, Parkinson’s disease, oesophageal cancer, brain tumours and toxicology.

The research projects will be undertaken at five universities in England and Scotland. Their collective aim is to further the understanding and treatment of life threatening diseases while simultaneously developing alternative methods to replace the use of animals in biomedical research.

The potential number of animals to be saved from invasive and painful procedures as a result of the success of these projects is immeasurable.

The new projects aim to:
• Improve understanding of the role of proteins in development and cell function that will lead to a better understanding and treatment of Alzheimer’s disease (Royal Holloway University)

• Develop the use of plant cells to emulate the development of Parkinson’s disease in human cells (Westminster University)

• Three dimensional cell model to allow the study of Barrett’s oesophagus and its progression to cancer (Dundee University)

• Generate human liver cells from pluripotent human stem cells to replace animals in toxicology (Edinburgh University)

• Utilize an effective 3D blood-brain barrier model to identify nanoparticle systems which may be effective drug carriers used to combat brain tumours and other neurological diseases (Portsmouth University)

Kailah Eglington, Chief Executive of the Dr Hadwen Trust, said: “We are delighted to announce funding for a further five ground-breaking, new research projects which promise to deliver benefits to both humans and animals. Each of these projects promises to significantly increase our understanding of devastating diseases whilst replacing animals used in scientific research.”

To find out more about the DHT research grants, please visit: www.drhadwentrust.org/research-and-funding/current-portfolio.

2012 Call for Grant Applications
The DHT is also making its annual call for applications for the next wave of grants: www.drhadwentrust.org/research-and-funding/research-funding-overview.

Awarded in summer 2013, the deadline for preliminary applications is 17th December 2012.

Kailah Eglington, continues: “In making research grants available annually, we are urging all scientists to think about how they can help shape a more effective and humane future for medical research by using non-animal methods in their work.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!